Clinical trials
Completed Pulmonary Fibrosis trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 2 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 4 |
| Boehringer Ingelheim | 4 |
| Hospices Civils de Lyon | 2 |
| Bristol-Myers Squibb | 1 |
| Centre Hospitalier Universitaire de Nice | 1 |
| Debiopharm International SA | 1 |
| Dieulefit Santé Centre de Réadaptation | 1 |
| Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires | 1 |
| Hopital Foch | 1 |
| Institut National de la Santé Et de la Recherche Médicale, France | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Fibrosis | 21 |
| Lung Diseases, Interstitial | 6 |
| Idiopathic Pulmonary Fibrosis | 3 |
| Scleroderma, Diffuse | 3 |
| Scleroderma, Systemic | 2 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 |
| Arthritis | 1 |
| Combat Disorders | 1 |
| Connective Tissue Diseases | 1 |
| Dyspnea | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.